Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2022 | Targeting ER stress to preserve cardiac function in patients with AL amyloidosis

Panagiota-Efstathia Nikolaou, PhD, National and Kapodistrian University of Athens, Athens, Greece, comments on the need to develop better therapies in patients with AL amyloidosis with cardiac involvement, highlighting the potential of targeting endoplasmic reticulum (ER) to alleviate cardiac damage in those patients. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.